Article
APOBEC3A/B deletion polymorphism and cancer risk.
Carcinogenesis - 9 Feb 2018
Gansmo Liv B, Romundstad Paal, Hveem Kristian, Vatten Lars, Nik-Zainal Serena, Lønning Per Eystein, Knappskog Stian
Abstract excerpt
Activity of the apolipoprotein B mRNA editing enzyme, catalytic-polypeptide-like (APOBEC) enzymes has been linked to specific mutational processes in human cancer genomes. A germline APOBEC3A/B deletion polymorphism is associated with APOBEC-dependent mutational signatures, and the deletion allele has been reported to confer an elevated risk of some cancers in Asian populations, while the results in European...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
